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Magnetic resonance imaging (MRI) with gadolinium based contrast agents (GBCA)
is routinely used in the clinic to visualize lesions in multiple sclerosis (MS). Although
GBCA reveal endothelial permeability, they fail to expose other aspects of lesion
formation such as the magnitude of inflammation or tissue changes occurring at sites
of blood-brain barrier (BBB) disruption. Moreover, evidence pointing to potential side
effects of GBCA has been increasing. Thus, there is an urgent need to develop
GBCA-independent imaging tools to monitor pathology in MS. Using MR-elastography
(MRE), we previously demonstrated in both MS and the animal model experimental
autoimmune encephalomyelitis (EAE) that inflammation was associated with a reduction
of brain stiffness. Now, using the relapsing-remitting EAE model, we show that the
cerebellum—a region with predominant inflammation in this model—is especially prone
to loss of stiffness. We also demonstrate that, contrary to GBCA-MRI, reduction of brain
stiffness correlates with clinical disability and is associated with enhanced expression
of the extracellular matrix protein fibronectin (FN). Further, we show that FN is largely
expressed by activated astrocytes at acute lesions, and reflects the magnitude of tissue
remodeling at sites of BBB breakdown. Therefore, MRE could emerge as a safe tool
suitable to monitor disease activity in MS.
Keywords: magnetic resonance elastography, experimental autoimmune encephalomyelitis, extracellular matrix,
fibronectin, gadolinium-based contrast agent, multiple sclerosis
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INTRODUCTION
Multiple sclerosis (MS) is a chronic inflammatory disease of
the central nervous system (CNS) that represents the most
common cause of non-traumatic disability in young adults.
MS is considered to be an autoimmune disease in which self-
reactive immune cells gain access to the CNS leading to myelin
destruction and neuronal damage and the subsequent formation
of multifocal lesions (1). These pathological hallmarks are also
characteristic for experimental autoimmune encephalomyelitis
(EAE), which is the prototypical model for MS (2).
In MS, clinical relapses correlate with the development
of perivenular inflammatory lesions inside the CNS. Lesion
monitoring is commonly required to make an accurate diagnosis
and to monitor disease progression and response to treatment.
Typically, new lesions are visualized using gadolinium-based
contrast agents (GBCA) on MRI. During active inflammatory
processes, GBCA cross the leaking blood-brain barrier (BBB),
enter the CNS parenchyma, and alter the magnetic properties
of the tissue, reducing the T1 relaxation time. Generally, the
more severe the inflammatory activity, the greater the burden
of GBCA-enhancement on post-contrast T1-weighted scans (3).
However, GBCA-MRI has limitations due to safety reasons and
lack of sensitivity. We previously showed in EAE that certain
lesions may remain undetectable by GBCA (4, 5). Furthermore,
there are emerging concerns that GBCAmay deposit in the tissue
after repeated applications (6).
Magnetic resonance elastography (MRE) could represent a
promising alternative to the use of GBCA. MRE provides
information about the mechanical properties of tissues (7, 8)
by analyzing their response to oscillatory shear stress (9).
Using MRE, we reported on reduced brain viscoelasticity
in patients with clinically isolated syndrome (10) as well
as patients with established relapsing-remitting (11) and
chronic-progressive (12) MS. Brain tissue softening was also
observed in patients with a neuromyelitis optical spectrum
disorder (NMOSD) (13). However, the mechanisms underlying
brain softening in patients remain elusive. Our aim is
therefore to dissect these mechanisms using animal models of
neuroinflammation. Application of MRE in the cuprizone mouse
model of demyelination demonstrated that brain softening was
associated with demyelination (14). The observed reduction of
brain viscoelasticity in this model was not related to tissue
inflammation. However, in the EAE model of MS, we previously
showed that inflammation was associated with reduced brain
elasticity on MRE (15, 16).
In the present study, we evaluated the capacity of MRE
to reveal acute inflammatory activity and disease severity,
comparing sagittal MRE with conventional GBCA-MRI in the
relapsing-remitting EAE model. Furthermore, we aimed to
clarify the nature of the tissue alterations at lesion sites by
examining changes to the extracellular matrix (ECM). For this we
concentrated attention on the proteoglycan fibronectin (FN), as
it has been shown to accumulate within perivascular lesions, and
correlate with the degree of inflammation (17, 18). We thereby
endeavor to improve our understanding of pathological changes
detected by MRE but not by conventional GBCA-MRI.
METHODS
Animals
All procedures were approved by the Animal Welfare
Department of the State Office of Health and Social Affairs
Berlin (LAGeSo), in accordance with national and international
guidelines to minimize discomfort to animals (86/609/EEC).
Experimental SJL mice (Charles River Laboratories, Sulzfeld,
Germany) were housed in the central animal facility of the
Charité—Universitätsmedizin Berlin. All animals were kept
in a temperature- and humidity-controlled colony room and
maintained on a light/dark cycle of 12/12 h with ad libitum
access to food and water. Over multiple experiments, mice were
divided into two groups, EAE (n = 25) and non-manipulated
healthy control (n= 7).
Experimental Autoimmune
Encephalomyelitis (EAE)
To induce EAE (2, 19), SJLmice were immunized subcutaneously
with 250 µg proteolipid protein (PLP) peptide 139-151 (purity
95%; Pepceuticals, Leicester, UK) and 800 µg Mycobacterium
tuberculosis H37Ra (Difco, Franklin Lakes, NJ, USA) emulsified
in 100 µl Complete Freund’s adjuvant (CFA) and 100 µl
phosphate-buffered saline (PBS). Pertussis toxin (250 ng per
mouse; List, Biological Laboratories, Campbell, CA, USA) was
injected intraperitoneally on the day of immunization (day 0)
and again 2 days later (day 2). After immunization, mice were
monitored daily for clinical signs and scored as follows: 0, no
disease; 0.5, tail paresis; 1, tail paralysis; 1.5, tail paralysis and
righting reflex weakness; 2, hind limb paralysis (one limb);
2.5 Hind limb paralisis and paresis of the other hind limb; 3,
paraplegia; 4, paraplegia with forelimb weakness or paralysis; 4.5,
moribund with tetraparesis or tetraplegia; and 5, dead.
In vivo Scans
In vivo MRE and MRI scans were performed as described
previously (16) on a 7 T Bruker Pharmascan 70/16 rodent
MR scanner (Bruker Biospin, Ettlingen, Germany), running
Paravision 5.1 software, with a 20mm RF quadrature volume
head coil (RAPID Biomedical GmbH, Rimpar, Germany). Mice
were anesthetized with 1.5–2.0% isoflurane in 30% O2 and 70%
N2O administered via face mask, with continuous respiration
monitoring using a pressure-sensitive pad placed on the thorax
(Small Animal Instruments Inc., Stony Brook, NY, USA). The
animals were placed on a bed with circulating heated water
to maintain constant body temperature. In those animals
investigated by both MRE and MRI, the MRE measurements
were acquired first, followed by GBCA-MRI after 24 h.
Magnetic Resonance Elastography (MRE)
The MRE images were acquired in one 2mm midsagittal slice as
described previously (16). Mechanical vibration was generated
by an air-cooled electromagnetic Lorentz coil in the fringe field
of the MRI scanner. Vibrations were initiated by a trigger pulse
from the control unit of the MRI scanner, and transferred to the
animal through a carbon fiber piston, which was connected to
the bite bar transducer. The transducer was gimbaled through
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a rubber bearing and retaining bracket at the temperature-
controlled mouse bed. A plastic disk held up the entire setup in
the center of the magnet bore (16).
The timing of the vibration was defined and recorded by a
fast low-angle shot (FLASH) sequence especially made for MRE
measurement. The direction of the motion sensitizing gradient
(MSG), with a strength of 285 mT/m, a frequency of 900Hz,
and 9 periods, was maintained parallel to the principal axis
of the magnetic field (maximum amplitude of the mechanical
driver was 10 microns). To compensate for the static phase
contributions, phase difference images were calculated from two
images differing in the sign of the MSG. Frequency amplitude
and the number of cycles were controlled by a waveform
generator connected via an audio amplifier to the driving coil.
Additional scan parameters were as follows: TE = 14.3ms; TR
array = 166.0ms; slice thickness = 2.0mm; matrix = 128,
FOV = 25mm; two averages; eight dynamic scans over a
vibration period and an acquisition time of 12 min.
MRE Data Analysis
Complex wave images corresponding to the harmonic drive
frequency were extracted by temporal Fourier transformation
of the unwrapped phase-difference images. To reduce noise, in
addition to the Butterworth band pass filter, a spatiotemporal
directional filter was applied to the wave images (20). The
spatiotemporal filter filtered waves that were propagating from
bottom-to-top in the sagittal slice. A 2D-Helmholtz inversion
was performed to the filtered data, yielding the complex shear
modulus G∗ and the magnitude modulus |G∗| = abs (G∗). The
calculated spatially averaged G∗-values were represented by the
real part of the complex shear modulus G’ = Re (G∗), known
as the storage modulus that represents tissue elasticity, and
the imaginary part G′ = Im (G∗), which is the loss modulus
representing tissue viscosity. The magnitude, storage and loss
moduli were expressed in pascals (Pa). The loss factor calculated
as the phase angle phi= arctan (G′′/ G′) represents the fluidity of
the tissue, which is the degree of viscosity relative to elasticity and
is interpreted as being sensitive to the architecture of viscoelastic
networks in biological tissues (21). In addition to calculating
values for the storage and loss moduli for the entire sagittal slice,
the brain was separated into two regions of interest divided at the
junction between the cerebrum and the cerebellum.
Magnetic Resonance Imaging (MRI)
T1 maps were generated using a saturation recovery RAREVTR
method, in which the repetition time (TR) was varied to
acquire a series of axial T1 weighted images, from which
the T1 map was produced. Scan parameters were as follows:
TE = 8.3ms; TR array = 230, 460, 1061, 1485, 2080, 3080
and 7500ms; flip angle = 90◦/180◦; RARE factor = 2; slice
thickness = 1.0mm; matrix = 128, FOV = 1.92 cm; NA = 1,
10 slices, scan time = 17min 44 sec. After acquiring the pre-
contrast T1 map, the animals were administered 0.2 mmol/kg
gadopentate dimeglumine (Gd-DTPA, Magnevist, Bayer Vital
GmbH, Leverkusen, Germany) by intravenous injection. After
5min, the post-contrast T1 maps were acquired using the same
parameters as above. Data acquisition was done with ParaVision
5.1 (Bruker Biospin, Germany). The raw data files were exported
as NIFTI image files, and analyzed in ImageJ v. 1.51 (NIH,
open source). A region of interest (ROI) defining the brain was
manually traced for all 10 slices, and the mean T1 value of each
ROI calculated. The mean T1 from all 10 slices was determined
for each animal, and the post-contrast mean was subtracted from
the pre-contrast mean, to yield the difference—delta T1. The
delta T1 was used for the statistical analysis.
In addition, T1-weigthed images were acquired as described
previously (22). As a complimentary method, we also calculated
the T1 signal intensity change directly from the T1-weighted
images. An ROI defining the brain was manually traced for 20
slices and the mean signal intensity (SI) value of each ROI was
calculated. The mean SI from all 20 slices was determined for
each animal in both pre- and post-contrast, calculated as: signal
intensity change (SI%) = [(SI post-contrast—SI pre-contrast)/SI
pre-contrast] ∗ 100.
Tissue Processing
Mice were sacrificed 1 day after MRE and MRI measurements.
Animals were deeply anesthetized with ketamine/xylazine, then
transcardially perfused with PBS. Twenty-five brains were
extracted and 19 of them were cut sagittally in two symmetrical
halves. Half of the brain was postfixed in 4% paraformaldehyde
(PFA) overnight at 4◦C and then PBS washed, followed by 30%
sucrose in PBS, soaking until the tissue sunk to the bottom.
Meanwhile, the other half of the brain was reserved for RNA
extraction. For histological analysis, brain tissue was embedded
in O.C.T., frozen in methylbutane with dry ice, and stored at
−80◦C. For analysis, frozen tissues were cut into 12µm coronal
or sagittal cryosections and stored at 4◦C.
Histology and Immunofluorescence
For Immunostaining, brain sections were permeabilized and
blocked with PBS containing 10% normal goat serum, 10%
bovine serum albumin and 0.3%Triton TMX-100 for 1 h at room
temperature. Sections were incubated overnight at 4◦C with the
primary antibodies diluted in PBS. Primary antibodies included:
rabbit anti-fibronectin, 1:200 (Millipore ab2033); mouse anti-
EIIIA-fibronectin, 1:200 (Abcam ab6328); chicken anti-GFAP,
1:500 (Abcam ab4674). For double labeling immunostaining,
primary antibodies were incubated sequentially. For staining
with the mouse anti-EIIIA-fibronectin (IST9), we used a mouse
on mouse (M.O.M.) kit from Vector Laboratories. After staining
with primary antibodies, sections were washed with PBS and
incubated with Alexa Fluor (488 or 647, 594)-conjugated
secondary antibodies (1:400) at room temperature for 2 h,
followed by 4′,6-diamidino-2-phenylindole (DAPI) to visualize
cell nuclei. Sections were imaged using a Zeiss Axio Observer
fluorescence microscope or a laser-scanned confocal microscope
(LSM 710, Carl Zeiss, Jena, Germany).
Quantitative Reverse-Transcription PCR
The brain tissue for PCR was divided into two portions,
the anterior (cerebral) and posterior (cerebellar) region,
according to the MRE scanning regions. Total RNA was
extracted from the tissue by using the Trizol method. The
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RNA was reverse transcribed, and quantitative PCR (qPCR)
carried out as described previously, using an ABI Prism 7000
SequenceDetection System (Applied Biosystems, Darmstadt,
Germany) (16). Primers and probes were from Eurofins MWG
Operon (Ebersberg, Germany), and the sequences used were
as followed: Fibronectin, forward 5′-ATCATTTCATGCCAAC
CAGTT-3′, reverse 5′-TCGCACTGGTAGAAGTTCCA-3′,
probe 5′FAM-CCGACGAAGAGCCCTTACAGTTCCA-
3′TAMRA. Neurocan, forward 5′-GGTGTGCGCACTGTGTA-3′,
reverse 5′-CATGTTGTGCTGTATGGTGATG-3′, probe 5′FAM-
TTCGACGCCTACTGCTTCCGAG-3′TAMRA. Brevican,
forward 5′-AGAACCGCTTCAATGTCTACTG-3′, reverse 5′-
ACTGTGACAATGGCCTCAAG-3′, probe 5′FAM-ACTCTGCC
CATCCCTCTGCTTC-3′TAMRA. Glypican5, forward 5′-GAGA
CACTTGCCAACAGAAGA-3′, reverse 5′-GGGCAGCCAATT
CATTAACAC-3′, probe 5′FAM-CATGGGTCCTTCTATGGTGG
CCTG-3′TAMRA. 18s, served as the endogenous reference,
forward 5’-TTCGAACGTCTGCCCTATCAA-3′, reverse 5′-TCCC
CGTCACCCATGGT-3′, probe 5′FAM- TGATGTTTATTGACAA
CACGCTTTACTTTATACCTGAAGA-3′TAMRA. We used the
2−11CT method to analyze the results.
Statistical Analysis
Data were analyzed by unpaired two-tailed t-test, paired two-
tailed t-test or repeated-measures analysis of variance (ANOVA),
as appropriate. The non-parametric Spearman correlation was
used to assess correlation between MRE parameters and EAE
score. Pearson correlation was used to assess correlation between
imaging parameters, and between MRE parameters and the PCR
or immunostaining quantification data. Analysis was done using
GraphPad Prism v.5.01. (GraphPad software, La Jolla, CA, USA).
∗p< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001.
RESULTS
During Relapsing-Remitting EAE, Brain
Viscoelasticity Is Altered Particularly in the
Cerebellum
To assess the sensitivity of the sagittal MRE protocols in the SJL
EAE model (16), we monitored mechanical brain changes in SJL
mice immunized with PLP. Mice developed a typical relapsing-
remitting disease course, showing first clinical signs by 9–10 days
after immunization, reaching peak disease 3–4 days later (day
12-14 p.i.; Figure 1A). MRE measurements were performed at
day 14 post-immunization, when clinical signs of disease were
well-established and coinciding with the expected disease peak.
MRE data were acquired in one 2mm midsagittal slice and
confirmed our previous MRE data in relapsing-remitting EAE
acquired in coronal slices (15). We observed that at day 14–
15 p.i. the overall viscoelasticity of the tissue (|G∗| magnitude
modulus) as well as the storage modulus G’ (elasticity) and the
loss modulus G” (viscosity) were significantly diminished in EAE
mice compared to controls (Figures 1B–D). No alteration of the
phase angle (loss factor) was observed (Figure 1E), indicating
that the overall architecture of the brain tissue was not affected
by acute inflammation.
We previously showed in C57/BL6 mice that different brain
regions also show distinct viscoelastic properties (16). However,
it remained unclear whether this was also applicable in the
FIGURE 1 | Brain viscoelasticity in EAE and control mice. (A) EAE clinical course of SJL mice immunized with PLP. EAE mice reached the maximal score at day 12–14
after immunization, mean with SEM. At days of expected peak disease, EAE mice showed significant reductions of (B) magnitude modulus, (C) storage and (D) loss
modulus, compared to healthy controls. (E) No alteration of the phase angle was observed in EAE mice. Unpaired two-tailed t-test, *p < 0.05, mean ± SD.
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FIGURE 2 | Comparisons of regional brain viscoelasticity. (A) Sagittal views of an EAE mouse brain showing a representative magnitude image with definitions of the
cerebrum/anterior (red) and cerebellum/posterior (blue) regions (1), a wave (deflection) image (2) and a map of the complex modulus superimposed on the magnitude
image (3). (B) Comparison of the viscoelastic properties of the posterior/cerebellar region with the anterior region and the whole brain during inflammation. Repeated
measures ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001. (C) Delta MRE values at the time of the expected disease peak normalized to the values of age- and
gender-matched healthy animals. The magnitude modulus—i.e., the tissue rigidity—is particularly diminished in the posterior region (cerebellum) compared to the
anterior region (cerebrum). Data from five independent experiments n = 25. Paired two-tailed t-test, *p < 0.05, mean ± SD.
SJL EAE model, and whether different brain regions may also
differ in the MRE values during relapsing-remitting EAE. A
representative example of a midsagittal slice from a SJL EAE
mouse is shown in Figure 2A, illustrating the magnitude image
A (1), the wave deflection image A (2) and the magnitude
of the complex shear modulus |G∗| A (3). The acquisition of
MRE data in midsagittal slices permits the separate analysis of
the anterior region (cerebrum) and the posterior brain region
(cerebellum) (ROIs in Figure 2A-1). The results show that during
EAE, the cerebellum shows a striking reduction of themagnitude,
storage and loss moduli, when compared with the cerebrum or
the whole brain (Figure 2B). The phase angle remained stable
in the investigated regions. Furthermore, to estimate the effect
of disease in these two different brain regions, we calculated
the viscoelastic changes of the EAE tissue in relation to sex
and age matched healthy controls. Figure 2C demonstrates that
viscoelastic values at the time of the expected peak of EAE were
decreased in both regions when normalized to healthy mice,
as indicated by mean difference 1|G∗| < 0, indicating that
during EAE both regions undergo a “softening” of the tissue.
Nevertheless, the magnitude modulus decreased more strikingly
in the cerebellum, consistent with the fact that this region is more
affected by inflammatory pathology than the cerebrum in the SJL
EAE model.
Sagittal MRE Measurements Show a
Correlation Between Mechanical Brain
Properties and Clinical Disability in the
Relapsing-Remitting EAE Model
It is well-established in both MS patients (23) and EAE
(24), that MRI measurements do not always correlate with
clinical disability. Using MRE acquired in the sagittal plane,
we observed statistically significant correlations between the
magnitude and storage moduli and the clinical score on the
day of MRE acquisition, p = 0.0117, r = −0.6306 and
p = 0.0373, r = −0.5411, respectively (Figures 3A,B). No
significant correlations between loss modulus, phase angle and
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FIGURE 3 | Correlation of EAE clinical score and whole brain viscoelasticity.
(A) Negative correlation was observed between clinical disability and
magnitude modulus (p = 0.0117, r = −0.6306) as well as (B) storage
modulus (p = 0.0373, r = −0.5411). No correlation was observed with (C)
loss modulus and (D) phase angle. Data from five independent experiments,
including only symptomatic mice, n = 15. Spearman correlation, *p < 0.05.
EAE score were observed (p = 0.1211 and r = −0.4179,
p = 0.6189 and r = −0.1399, respectively Figures 3C,D).
These results indicate that there is an association between brain
softening and more severe clinical signs in EAE mice.
MRE Does Not Correlate With Gadolinium
Enhancement in Acute EAE
Contrast agent-based MRI represents the standard MR tool in
MS to detect acute inflammatory lesions (25). Therefore, we
asked whether the intensity of gadolinium (Gd) enhancement
in brain MRI also correlated with clinical disability and MRE
values in the SJL EAE model. We acquired axial and coronal
T1-weighted images before and after intravenous injection of 0.2
mmol/kg Gd contrast agent, 24 h subsequent to the MRE scans.
Brain lesions in active EAE are unevenly distributed in space,
and are highly diffuse, lacking clear boarders. In order to better
evaluate the extent of these diffuse lesions, we generated T1 maps
to yield a quantitative measure of brain tissue contrast changes
resulting from GBCA leakage across the blood-brain barrier. The
T1 values were averaged from ROIs defining the entire brain,
in order to obtain a global metric of Gd enhancement in the
whole brain. Representative images illustrating the T1 maps pre-
and post-contrast are shown Figure 4A. As expected, the post-
contrast T1 values for all animals were significantly reduced,
compared to the pre-contrast values (data not shown). Contrary
to expectations, there was no statistically significant correlation
between the delta T1 and the magnitude modulus (p = 0.8797,
r = 0.05181, Figure 4B) or between T1 signal intensity changes
directly obtained from the whole brain T1-weighted images and
MRE values (p= 0.3402, r= 0.2315, Figure 4C). Accordingly, no
significant correlation was observed between T1 signal intensity
changes and EAE scores of the mice (p = 0.2325, r = −0.4195,
Figure 4D).
Reduction of Viscoelasticity Correlates
With an Increased Expression of FN
In view of the correlation between acute inflammatory events
and loss of brain stiffness as measured by MRE, we considered
whether viscoelastic changes may reflect processes of molecular
remodeling that occur during the formation of brain lesions.
Here we found that reduced viscoelasticity during EAE was
significantly correlated with increased gene expression of FN
in brain tissue, p = 0.0041, r = −0.9473 (Figure 5A). This
correlation was robust, and was also confirmed in a separate
analysis using frozen tissue from our previous study in SJL EAE
acquiring MRE data in the coronal orientation (15), p = 0.0163,
r =−0.6737 (Figure 5B).
To assess whether this association may involve changes
of other components of the ECM, we investigated the gene
expression of other key ECM proteoglycans, associated with the
BBB (eg. glypican 5), or with the perineuronal and interstitial
matrix (e.g., neurocan and brevican). No significant correlation
was observed between brain viscoelasticity and the expression
of these key proteoglycans, p = 0.9755 and r = −0.01632,
p = 0.3062 and r = −0.5056, p = 0.8671 and r = −0.08886,
respectively (Figure 5C).
FN Deposits Are Predominantly Found in
Perivascular Areas, and Reduced
Viscoelasticity Correlates With Increased
FN Protein Expression
To confirm that FN gene expression is associated with protein
deposits, we performed immunohistochemical analysis in the
corresponding tissue, and demonstrated that at the time of
the expected peak of EAE severity FN was highly expressed
in perivascular areas (Figure 6A). In agreement with the gene
expression data, reduced viscoelasticity correlated with increased
FN immunofluorescence intensity (Figure 6B). In particular,
a significant correlation was observed with the magnitude
modulus and storage modulus (p = 0.0083, r = −0.8447 and
p = 0.0127, r = −0.8201, respectively); whereas, no correlation
of FN immunostaining with the loss modulus or phase angle
could be detected (p = 0.1766, r = −0.5301 and p = 0.2889,
r =−0.4290, respectively).
FN present in the lesions may arise either from the circulating
plasma Fn (pFn), deposited following BBB disruption, or
synthesized locally by glial cells (cellular cFn). These two FN
variants contain alternatively spliced domains, EIIIA and EIIIB.
To clarify the source of the FN observed in EAE, we used an
anti EIIIA-FN antibody (IST9), which only recognizes cellular
FN, in combination with the broad-spectrum anti-FN antibody.
The staining of cellular FN showed a consistently overlapping
pattern with the total FN, indicating that the main source of
the perivascular FN deposits was indeed cellular, rather than
circulating pFn (Figure 6C). The co-staining of FN with the
astrocytic marker GFAP further indicated that not only astroglia
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FIGURE 4 | Comparison of whole brain contrast-enhancing lesion burden with whole brain viscoelasticity. (A) Representative T1-weighted MR images pre- (left) and
post- (right) GBCA administration. A diffuse contrast-enhancing lesion is seen in the cerebellum (arrow). T1 map pre- and post-contrast with T1 relaxation time in ms.
Scale bar = 5mm. (B) Delta T1 (mean pre-contrast minus mean post-contrast) did not correlate with the magnitude modulus (Pearson correlation, p = 0.8797,
r = 0.05181). (C) T1 signal intensity changes (SI%) obtained from the T1-weighted images following Gd application showed no correlation with the magnitude
modulus (Pearson correlation, p = 0.3402, r = 0.2315). (D) There was no significant correlation between SI% and the EAE score (Spearman correlation, p = 0.2325,
r = −0.4195). Data from two independent experiments, n = 11 and n = 19 in (B–D), respectively.
but also endothelial cells may be major sources of FN production
in the lesion sites (Figure 6D).
DISCUSSION
In this study, we investigated the capacity of MRE to detect
acute inflammatory events in the mouse brain during relapsing-
remitting EAE. MRE investigations were performed together
with T1-weighted MRI using GBCA and were correlated with
clinical disability. Furthermore, we assessed the association
between MRE values and molecular aspects of extracellular
matrix remodeling at the sites of inflammatory lesions.
Studies using MRE to show changes in brain tissue stiffness
in the context of pathology should consider the baseline
values of normal brain, though it is crucial to take into
consideration technical differences among various research
groups. For example, Murphy et al. used a higher stimulation
frequency (1,500Hz), yielding highermouse brain stiffness values
(25.0 kPa) (26). Other studies using stimulation frequencies
similar to the setup in the current study show that the values
we obtained are within the range of other published values
[reviewed in Table 1 of Bertalan et al. (27)]. Consistent with
our previous studies using coronal MRE (15), we show here
that MRE using sagittal slices in SJL EAE revealed a decrease
in the overall brain viscoelasticity at the time of the expected
peak of disease, compared to the corresponding healthy controls.
Furthermore, confirming our data in C57/BL6 mice (16), we
demonstrated also in SJL mice that the cerebellum is softer
than the cerebrum, and that these regional differences were
maintained during EAE. In the SJL model, it is well-documented
that the cerebellum is especially susceptible to blood-brain-
barrier disruption and lesion formation (28). This together with
the significant softening of the cerebellum suggests that areas
of high inflammatory activity are especially well-identified by
MRE. However, confirming the sensitivity of the sagittal MRE
scans for visualizing whole brain inflammation, we observed a
significant correlation between whole-brain brain viscoelasticity
and EAE clinical score. No correlation was established between
cerebellar viscoelasticity and EAE score. Thus, although changes
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FIGURE 5 | Association between viscoelastic changes and expression of FN.
(A) The degree of reduction of cerebellar rigidity (magnitude modulus) at time
of the expected EAE peak is associated with increased expression of FN
assessed by qPCR, p = 0.0041, r = −0.9473. (B) The same association
between magnitude modulus and fibronectin expression was found using
frozen tissue from our previous study in SJL EAE with coronal MRE.
P = 0.01163, r = −0.6737. (C) No correlation was observed between
cerebellar magnitude modulus and gene expression of other ECM components
of the cerebellum including glypican5, neurocan and brevican, respectively.
Pearson correlation, **p < 0.01. Data from two independent experiments,
including only symptomatic mice, n = 12 and n = 6 in (A–C), respectively.
in the cerebellum are relevant and pronounced, they do not seem
to reflect all the processes that ultimately determine the clinical
EAE signs.
To date, GBCA-MRI represents the standard approach to
identify BBB breakdown in MS patients and also in animal
models (29–31). However, there is increasing concern from
recent studies and case reports pointing out potential toxic
side effects of GBCA (32), thus motivating the desire for
alternative MRI methods that can both better detect and improve
understanding of the nature of the pathology during disease. In
the active EAE model, GBCA-enhancing lesions are numerous,
but rather small and diffusely distributed, and are thus inherently
difficult to quantify using T1-weighted images. Therefore, we
used T1 mapping to yield an unbiased, quantitative readout of
the burden of lesion activity in the entire brain—a strategy that
was recently applied in a mouse brain tumor model (33). Using
the delta T1 averaged over the entire brain as a metric of BBB
disruption also avoids potential sampling bias that might occur
when attempting to quantify lesions in selected brain slices, given
the uneven distribution of brain lesions in SJL EAE. Contrary to
our expectations, there was no significant correlation between the
overall magnitude of GBCA-enhancing lesions and the whole-
brain MRE parameters. This underscores the complex nature
of multiple pathological processes that occur simultaneously in
EAE. It may be that the relationship between viscoelastic changes
and GBCA-enhancement cannot be detected with a simple linear
correlation. This may reflect that the disease processes that lead
to viscoelastic changes have different kinetics from those of acute
BBB disruption and active lesions. This remains a topic for
further investigations.
Inflammatory lesions are not only defined by enhanced
endothelial permeability and disruption of the BBB, but also by
astroglial activation and remodeling of the extracellular matrix
components (34). In particular FN-mediated signaling seems to
promote vascular remodeling during demyelinating disease (35).
Therefore, we investigated the relationship between alteration
of mechanical properties of the brain and expression of FN,
as an indicator for neurovascular junction remodeling during
lesion formation. Our data indicate that reduction of brain
viscoelasticity is indeed associated with an overall increase of FN
expression in the brain tissue (36, 37).
FN is a multidomain glycoprotein binding to cell-surface-
receptors, mostly integrins, and to the ECM and appears in
two forms: plasma and cellular FN. Cellular FN is secreted
as a soluble covalent dimer, and in a complicated process
in which the FN molecule undergoes different conformational
changes, is assembled into a stable matrix (38). Our data
point to a cellular source of the FN deposits detected in the
perivascular areas. FN fibers were in close proximity to the
reactive astrocytes, confirming previous reports that glia cells are
major producers of the protein (39). However, further studies
are required to determine the sources of FN. So far, we could
not exclude other cellular sources such as brain endothelial
cells. Additionally, we observed that FN deposits characterized
disturbed BBB with enhanced perivascular space and astrocyte
endfoot detachment. Thus, although the FN fibers are extremely
elastic (40), and might be expected to contribute to enhanced
tissue elasticity, in this context their presence might reflect an
assembly of processes involved in disruption of the neurovascular
unit at the lesion sites. This may lead to tissue softening,
due to enhanced endothelial permeability, alteration of blood
flow, enlargement of the perivascular spaces, inflammation or
astrocytic endfeed detachment.
Importantly, the correlation of MRE data with FN deposition
could also be confirmed in brain tissue from our previous
MRE study in SJL animals, in which MRE data was acquired
using a coronal slice (15). In contrast, no correlation was
found between MRE values and other ECM components
such neurocan, brevican, or glypican, which are reported
to be relevant for neuroinflammation, but which do not
directly reflect the process of acute lesion formation (36, 37).
Furthermore, we found that deposits of FN are prominent
around inflamed vessels and that the presence of FN also
correlated with the overall softening of the brain tissue at
acute EAE.
Altogether our study sheds light on the mechanism of brain
softening due to inflammation. Previous studies inmouse models
and patients have demonstrated in vivo that brain tissue becomes
softer during the progression of neuroinflammatory processes.
Our data demonstrate that some of these observations might
be explained by mechanisms involving the enhancement of
perivascular spaces and astrocyte endfoot detachment leading
to weaker couplings between the neuronal-vascular networks,
and reduced tissue stiffness. This might also explain the high
sensitivity of MRE to processes of acute inflammation and
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FIGURE 6 | Association between viscoelastic changes and histological detection of FN. (A) Immunofluorescence staining indicates a perivascular distribution of FN
(green) in inflamed midbrain (top) and cerebellum (bottom). Staining of FN deposits are green and cell nuclei are blue, scale ba r = 100µm. (B) Correlation between
MRE parameters and FN immunofluorescence in EAE animals at days of expected peak disease. Data from two independent experiments, including only
symptomatic mice, n = 8. Pearson correlation, **p < 0.01, *p < 0.05. (C) Immunostaining with anti-FN for detection of overall fibronectin (red), and anti-EIIIA-FN for
detection of cellular FN (IST9, green) indicates that perivascular FN deposits are secreted by cells. Cell nuclei are blue. Scale bar = 100µm. (D) Immunostaining of FN
(green) and the astrocytic marker GFAP (yellow) shows perivascular astrocytes adjacent to the FN deposits in the EAE brain. Cell nuclei are blue. Scale bar = 100µm.
lesion formation in the brain when compared to GBCA-MRI.
The application of MRE in mouse models of brain disease is
an emerging field. Future experiments to evaluate how well
MRE can predict disease development in the pre-onset phase,
or to identify tissue changes and accurately reflect disease
severity during clinical relapse and remission, hold promise.
Further technical developments that will allow faster acquisition
times to obtain MRE data covering the entire mouse brain
with reasonable scan times, as well as improvements in spatial
resolution will be essential to advance our understanding of
the complex processes occurring during neuroinflammation.
The results of the present study lay a foundation for such
upcoming studies to investigate in more detail the temporal
and spatial changes of tissue mechanics in relation with
lesion development.
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